Home
Scholarly Works
Impact of a simple regimen of low molecular weight...
Conference

Impact of a simple regimen of low molecular weight heparin (reviparin) in preventing mortality, reinfarction, and strokes in over 15,500 patients with ST-elevation acute myocardial infarction: The CREATE trial

Authors

Xavier D; Yusuf S

Volume

149

Pagination

pp. 244-245

Publisher

MOSBY-ELSEVIER

Publication Date

February 1, 2005

Name of conference

77th Scientific Meeting of the American-Heart-Association

Conference place

New Orleans, LA

Conference start date

November 7, 2004

Conference end date

November 10, 2004

Conference proceedings

AMERICAN HEART JOURNAL

Issue

2

ISSN

0002-8703

Labels

Contact the Experts team